Balancing clinical targets and operational requirements

The HDx therapy in routine clinical practice

We believe every person suffering from kidney disease deserves the right therapy, at the right time, in the right clinical environment. What’s more, we understand that every patient, and clinic, is different and has different needs.

Because of this we offer two integrated systems intended to facilitate the delivery of the HDx therapy enabled by the THERANOVA dialyzer; this will give more clinics the ability to deliver improved clearance while maintaining their operational efficiency.

The AK 98 system

Designed to keep you on your path to target.

Find out more about the integrated HDx therapy on the AK 98 system below

Helping keep you on your path to target

The AK 98 system is designed to help healthcare professionals reach their clinical targets and increase operational efficiency. Find out more about the implementation of the HDx therapy on the AK 98 system and how they can help you overcome your challenges.

Your Concern?

Mortality and burden of treatment remain high in ICHD patients, despite many technological advances1,2

Our answer!

Elevated levels of large middle molecules are associated with inflammation and cardiovascular event3,4,5

Your Concern?

A majority of the large middle molecules are not cleared effectively using current HD Technologies6,7

Our answer!

The THERANOVA dialyzer features membrane innovation designed to target large middle molecules effectively8

Your Concern?

Switching to HDF requires new workflow and additional quality assurance procedures9

Our answer!

The HDx therapy enabled by the THERANOVA dialyzer is as simple as HD

Your Concern?

The implementation of HDF may require additional investment and increased running cost

Our answer!

The cost per treatment of the HDx therapy is similar to conventional HD

THERAPY WHEEL

An integrated treatment option achieving HDF performance and beyond as simple as HD

Consumables

Monitor & Features

Services & System

Close

CONSUMABLES

DIALYZERS

THERANOVA 400 & 500

BLOODLINES

NOVALINE

CONCENTRATES

BiCart

SoftPac Citrate

ULTRAFILTER

CLEANCART

Close

MONITOR & FEATURES

MONITOR

AK 98 SYSTEM

TREATMENT MONITORING

DIASCAN

BPM

Close

SERVICES & SYSTEM

IT

Bi-directional connectivity for data management with HL7 protocol

CLINICAL SERVICES

HDx learance App.

TECHNICAL SERVICES

Hotline

Technical Training

Service contract

WATER SYSTEM

CWP 100 or 800 with integrated heat disinfection

The Artis Physio system

Advanced modalities and enhanced user experience.

Find out more about the integrated HDx therapy on the Artis Physio system below

Deliver HDx with confidence with the Artis Physio system

The Artis Physio dialysis system provides a range of treatment modalities to meet patient needs through innovative technologies that are designed to simplify everyday operations and enhance user experience. Find out more about the combination of the HDx therapy and the HEMOCONTROL modality and how they can help you overcome your challenges.

Your Concern?

Intra Dialytic Hypotension (IDH) is the second most common patient-reported symptom during HD10

Our answer!

The HEMOCONTROL Biofeedback dialysis embedded in HDx-HC therapy reduces intradialytic hypotension by 39%11

Your Concern?

A majority of the large middle molecules are not cleared effectively using current HD Technologies6,7

Our answer!

The THERANOVA dialyzer features membrane innovation designed to target large middle molecules effectively8

Your Concern?

Consistent delivery of high volume post dilution HDF may be challenging9

Our answer!

The HDx therapy combined with the HEMOCONTROL modality is simple and can be delivered successfully to most patients

Your Concern?

Intra Dialytic Hypotension may impair the delivery of treatment targets.

Our answer!

The HDx therapy combined with the HEMOCONTROL modality can reduce nurse intervention and minimize disruption of treatment scheduling12

THERAPY WHEEL

An integrated treatment option achieving HDF performance and beyond as simple as HD

Consumables

Monitor & Features

Services & System

Close

CONSUMABLES

DIALYZERS

THERANOVA 400& 500

BLOODLINES

ARTISET

CONCENTRATES

BiCart

BiCart Select system

SoftPac Citrate

ULTRAFILTER

CLEANCART

Close

MONITOR & FEATURES

MONITOR

ARTIS PHYSIO SYSTEM

TREATMENT MONITORING

DIASCAN

BPM

HEMOCONTROL

Close

SERVICES & SYSTEM

IT

IT connectivity for data collection with HL7 protocol

Patient Card

CLINICAL SERVICES

HDx learance App.

TECHNICAL SERVICES

Hotline

Technical Training

Service contract

WATER SYSTEM

CWP 100 or 800 with integrated heat disinfection

References

  1. Norbert Lameire N, et al. (2009) Did 20 Years of Technological Innovations in Hemodialysis Contribute to Better Patient Outcomes? Clin J Am Soc Nephrol 4: S30–S40.
  2. Lee MB, Bargman JM. (2016) Survival by dialysis modality-who cares? Clin J Am Soc Nephrol. 11(6): 1083–7.
  3. Yilmaz MI, et al. (2007) Low-grade inflammation in chronic kidney disease patients before the start of renal replacement therapy: sources and consequences Clin Nephrol 68: 1-9.
  4. Stenvinkel P. (2013) Can Treating Persistent Inflammation Limit Protein Energy Wasting? Seminars in Dialysis 26(1): 16–39.
  5. Akchurin OM, Kaskel F. (2015) Update on Inflammation in Chronic Kidney Disease. Blood Purif 39: 84–92.
  6. Neirynck N et al. (2013) An update on uremic toxins. Int Urol Nephrol 45 139–150
  7. Leypoldt K et al. (2012) Clearance of Middle Molecules during Haemodialysis and Haemodiafiltration; New Insights. Nephrology Dialysis Transplantation 27: 4245-4247
  8. Kirsch A et al. (2017) Performance of hemodialysis with novel medium cut-off dialyzers. Nephrol Dial Transplant 32: 165-172
  9. Chapdelaine I et al. (2015) Optimization of the convection volume in online post-dilution haemodialfiltration: practical and technical issues. Clinical Kidney Journal 8: 191-198
  10. Caplin B, et al. (2011) Patients’ perspective of haemodialysis-associated symptoms. Nephrol Dial Transplant 26(8): 2656-2663
  11. Nesrallah GE, et al. Biofeedback dialysis for hypotension and hypervolemia: a systematic review and meta-analysis. Nephrol Dial Transplant. 2013;28:182–191.
  12. Doria M, et al. (2014) The dialysis staff workload and the blood volume tracking system during the hemodialysis sessions of hypotension-prone patients.In J Artif Organs. 37(4):292–298.
See all references